Inflammatory myofibroblastic tumour

Authors

  • Khushboo Garg Department of Obstetrics and Gynaecology, ESIC Manesar, Haryana, India
  • Monika Madaan Gaur Department of Obstetrics and Gynaecology, ESIC Manesar, Haryana, India
  • Annu Dabla Department of Obstetrics and Gynaecology, ESIC Manesar, Haryana, India
  • Ritu Dahiya Department of Obstetrics and Gynaecology, ESIC Manesar, Haryana, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20241452

Keywords:

IMT, ALK, Vimentin, CA 125, CEA, Carcinoma ovary

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rarely described tumor of unknown etiology and pathogenesis. An IMT may occur in almost any part of the body, from the central nervous system to the limbs, and has nonspecific clinical manifestations.  Histologically these lesions appear as an inflammatory infiltrate within a variable myofibrotic background. We here present a case of 67-year-old woman who presented with vague abdominal mass and her TAH with BSO was done in view of preoperative diagnosis of ovarian malignancy, which after histopathology came out to be IMT of pelvis.

References

Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press. 2002;91-3.

Ishioka S, Maeda A, Yamasaki M, Yamakido M. Inflammatory pseudotumor of the lung with pleural thickening treated with corticosteroids. Chest. 2000;117(3):923.

Casanova M, Brennan B, Alaggio R,Kelsey A, Orabach D, Van Noesel MM, et al. Inflammatory myofibroblastic tumour: the experience of European paediatric soft tissue sarcoma study group (Epssg).Eur J Cancer. 2020;127:123-9.

Lindberg MR, Cassarino DS, Gardner J, Lucas D, Quick CM, Stallings-Archer K. Diagnostic pathology - soft tissue tumors. 3rd ed. Elsevier. 2019;88-99.

Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509-20.

Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CDM, Bridge JA, Hogendoorn P, Mertenseds. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: International Agency for Research on Cancer. 2013;83-84.

World Health Organization Classification of Tumours; vol 5. Available at: https://tumourclassification.iarc.who.int. Accessed on 17th March 2023.

Dehner LP. The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding. J Pathol. 2000;192(3):277-9.

Ishioka S, Maeda A, Yamasaki M, Yamakido M. Inflammatory pseudotumor of the lung with pleural thickening treated with corticosteroids. Chest. 2000;117:923.

Surabhi VR, Chua S, Patel RP, Naoki T, Neeraj L, Srinivasa RP. Inflammatory myofibroblastic tumors: current update. Radiol Clin North Am. 2016;54(3):553-63.

Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemial and molecular analysis of 13 cases highlighting their broad morphologic spectrum. Mod Pathol. 2017;30(6):1489-503.

Downloads

Published

2024-05-29

Issue

Section

Case Reports